Mutya Harsch insider trades

Open-market stock purchases and sales by Mutya Harsch, CHIEF LEGAL OFFICER AND GC at VYNE Therapeutics Inc, from SEC Form 4 filings since Feb 27, 2018.

Recent trades

DateStockTradeValue
Jul 23, 2026VYNE VYNE Therapeutics IncSold (not open market)$20.2K
Mar 31, 2026VYNE VYNE Therapeutics IncSold (not open market)$2.4K
Dec 31, 2025VYNE VYNE Therapeutics IncSold (not open market)$2.1K

Companies traded

  • VYNE VYNE Therapeutics Inc: 1 buy, last Jul 23, 2026
  • STSA Satsuma Pharmaceuticals, Inc: other filings, last Jun 8, 2023
  • MNLO Menlo Therapeutics Inc: other filings, last Jun 30, 2020
  • FOMX Foamix Pharmaceuticals Ltd: 2 sales, last Mar 9, 2020

Get free alerts when Mutya Harsch files a new trade →